1Kane JM, Con'ell CU. Past and present progress in the pharmaco- logic treatment of schizophrenia [ J . J Clin Psychiatry, 2010,71 : 1115-1124.
2Maayan L, Vakhrusheva J, Correll CU. Effectiveness of medications used to attenuate antipsycbotic-related weight gain and metabolic abnormalities:a systematic review and meta-analysis [ J ]. Neuro- psychopharmacology,2010,35 : 1520-1530.
3Leucht S, Arbter D, Engel RR, et al. How effective are second-gen- eration antipsychotic drugs? A meta-analysis of placebo-controlled trials [ J ]. Mol Psychiatry,2009,14:429-447.
4Leucht S, Komossa K, Rummel-Kluge C, et al. A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia [ J ]. Am J Psychiatry, 2009,166 : 152-163.
6Lesile DL, Mohamed S, Rosenheck RA. Off label use of antipsy-chotic medications in the department of veterans affairs healthcare system J]. Psyehiatr Serv,2009,60 : 1175-1181.
7Brown S. Excess mortality of schizophrenia:a meta-analysis[ J]. Br J psychiatry, 1997,171:502-508.
8Hennekens CH, Hennekens AR, Hollar D, et al. Schizophrenia and increased risks of cardiovascular disease [ J ]. Am Heart J, 2005, 150:1115-1121.
9Newcomer JW, Hennekens CH. Severe mental illness and risk of cardiovascular disease [ J . JAMA, 2007,298 : 1794 -1796.
10Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death[J]. N Engl J Med, 2009,360 : 225 -235.
4Raedler TJ.Cardiovascular aspects of antipsychotics[J].Curr Opin Psychiatry,2010,23(6):574-581.
5Narang P,El-Refai M,Parlapalli R,et al.Antipsychotic drugs:sudden cardiac death among elderly patients[J].Psychiatry(Edgmont),2010,7(10):25-29.
6Trifiro G,Spina E,Gambassi G.Use of antipsychotics in elderly patients with dementia:do atypical and conventional agents have a similar safety profile?[J].Pharmacol Res,2009,59(1):1-12.
